Monday, July 16, 2018
 
 
Dr. Jennifer Edwards, MD is recognized by Continental Who's Who
MIDDLETON, N.J., July 13, 2018 /PRNewswire/ -- Dr. Jennifer Edwards, MD is recognized by Continental Who's Who as a Pinnacle Lifetime Member in the field of Psychiatry in recognition of her role as Child and Adolescent Psychiatrist and Owner of Jennifer Edwards M.D. LLC.   
 
Indivior Is Granted Preliminary Injunction on Generic (buprenorphine and naloxone) Sublingual Film
SLOUGH, England, July 13, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that the U.S. District Court for the District of New Jersey has granted a preliminary injunction (PI) against Dr. Reddy's Laborato.....
 
Freedom Superfoods Announces Launch of New Raw Organic Moringa Powder on Amazon
IPAYTOTAL, a UK based company that provides excellent High Risk Merchant Account Services, including offshore mercha...
 
European Prostate Cancer Market Outlook to 2026
DUBLIN, July 13, 2018 /PRNewswire/ --
 
Torchmark Corporation Announces Second Quarter 2018 Earnings Release And Conference Call
MCKINNEY, Texas, July 13, 2018 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) will release Second Quarter 2018 earnings after the market closes on Wednesday, July 25, 2018.  At that time a copy of the Company's Q2-2018 earnings press release and any other financial and statistical information.....
 
Buy One, Give One On Amazon Prime Day with Eye Love Products
United States - Amazon Prime Day (Monday, July 16 - 17th, 2018) is on the horizon, which is music to many ears around the world with internet. If you h...
 
Robert Teweleit pledges support for Houston SPCA
HOUSTON, July 13, 2018 /PRNewswire/ -- As a lifelong animal lover, however, and on a more personal level, a cause particularly close to Teweleit's heart is the Houston Society for the Prevention of Cruelty to Animals or Houston SPCA.
 



U.S. FDA Extends Review Timeline for INVOKANA® (canagliflozin) Supplemental New Drug Application
RARITAN, N.J., July 13, 2018 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) today announced that the U.S. Food and Drug Administration (FDA) has extended the review timeline for a supplemental New Drug Application (sNDA) for INVOKANA® (canaglif.....
 
Sangamo Therapeutics Announces Technology Leadership Changes
RICHMOND, Calif., July 13, 2018 /PRNewswire/ -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO) today announced that Michael Holmes, Ph.D., Senior Vice President and Chief Technology Officer, will resign from the Company effective July 20th to pursue an opportunity with a startup biotech company. Ed.....
 
Nevro to Announce Preliminary Second Quarter Worldwide Revenue, Discuss Full Year 2018 Revenue Guidance and Provide Business Updates

REDWOOD CITY, Calif., July 13, 2018 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that its management will be hosting a business update conference call before market open beginning at.....

 
U.S. FDA Approves XTANDI® (enzalutamide) for the Treatment of Men with Non-Metastatic Castration-Resistant Prostate Cancer (CRPC)
TOKYO and NEW YORK, July 13, 2018 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Appli.....
 
Luminex Corporation Second Quarter Earnings Release Scheduled for August 6, 2018
AUSTIN, Texas, July 13, 2018 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it expects to report results for the second quarter ended June 30, 2018 on Monday, August 6, 2018. A press release announcing the results is scheduled for release aft.....
 
Statement on event sponsorship and other promotional activities by federally licensed producers of cannabis
OTTAWA, July 13, 2018 /CNW/ - Health Canada is concerned by the decision of some federally licensed producers of cannabis for medical purposes to sponsor events, such as music festivals, and engage in other promotional activities, as reported recently by several Canadian media outlets.

 
Dr. Joshua Hare To Present Longeveron Regenerative Stem Cell Research At The Sixth Annual Aspen BrainLab
MIAMI, July 13, 2018 /PRNewswire/ -- Longeveron LLC, a biopharmaceutical company that develops stem cell therapies for aging-related diseases, announced that Dr. Joshua Hare, Chief Science Officer, will present at the sixth .....
 
FDA approves the first drug with an indication for treatment of smallpox
SILVER SPRING, Md., July 13, 2018 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved TPOXX (tecovirimat), the first drug with an indication for treatment of smallpox. Though the World Health Organization declared smallpox, a contagious and sometimes fatal infectious disease, eradicated in 1980, th.....
 


 
 
 
 
 
 
 
 
 
 
 
 
 





About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines